Delivery Order SPE2DB20D2014-SPE2DB25FD17F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $7,030.77 and is scheduled for completion by September 12, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within...
- The Defense Logistics Agency awarded a competitive delivery order valued at $46,871.80 to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. The order was placed on September 24, 2025, with an ultimate completion date of October 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors valued at $4,687.18, with completion targeted for September 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Tezspire 210 mg/1.91 ml pen auto-injectors. The contract is valued at $2,343.59 with a firm fixed price structure and is scheduled for completion by October 20, 2025. This competitively awarded order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $7,030.77 on September 19, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This firm fixed price, non-set-aside contract is scheduled for completion by October 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a specific pharmaceutical procurement within the company's...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. This firm fixed price delivery order is not set-aside and is scheduled for completion by August 1, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, was selected through competitive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $9,374.36 on August 18, 2025, with completion scheduled for September 9, 2025. The contract covers the supply of Tezspire 210 mg/1.91 mL pen auto-injectors and was funded through the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order represents a non-set-aside award, indicating open...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectables. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors, valued at $2,343.59 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 16, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a standard pharmaceutical...
- The Defense Logistics Agency awarded a $2,343.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors on August 11, 2025, with completion targeted for September 2, 2025. This is a non-set-aside, competitively awarded contract under which AmerisourceBergen will deliver the specified pharmaceutical product to support federal medical supply needs. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD17FDelivery Order
The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The delivery order represents a routine fulfillment of pharmaceutical supplies under DLA's Medical Supply Chain operations, which supports military healthcare systems and the Defense Health Agency. AmerisourceBergen's IDC serves as a prime vendor vehicle enabling the company to supply a broad range of brand-name and generic pharmaceuticals, vaccines, and medical devices to support military healthcare programs worldwide. The relatively modest order value reflects the transactional nature of individual delivery orders placed against the larger indefinite delivery contract framework, consistent with DLA's ongoing procurement of specialized medical commodities for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 9/29/25 |